The interleukin-10-1082 promoter polymorphism and cancer risk: A meta-analysis

Mutagenesis

Volumn 27, Issue 3, 2012, Pages 305-312

  Wang, Jing ^a   Ding, Qi ^a   Shi, Ying ^a   Cao, Qiang ^b   Qin, Chao ^b   Zhu, Jian ^b   Chen, Jiawei ^b   Yin, Changjun ^b  

^a Department of Neurology   (China)

^b THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10;

ARTICLE; BASAL CELL CARCINOMA; BLADDER CANCER; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; DNA POLYMORPHISM; ESOPHAGUS CANCER; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; GERM CELL TUMOR; HODGKIN DISEASE; HUMAN; KIDNEY CARCINOMA; LEUKEMIA; LIVER CELL CARCINOMA; LUNG CANCER; MELANOMA; META ANALYSIS; MYELOMA; NASOPHARYNX CARCINOMA; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; STOMACH CANCER; THYROID CANCER; TUMOR GENE; UTERINE CERVIX CANCER;

CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-10; LINEAR MODELS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; PUBLICATION BIAS;

EID: 84860167713     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/ger078     Document Type: Article

References (85)

1. Pharoah, P. D., Dunning, A. M., Ponder, B. A. and Easton, D. F. (2004) Association studies for finding cancer-susceptibility genetic variants. Nat. Rev. Cancer, 4, 850-860.
2. Kurzrock, R. (2001) Cytokine deregulation in cancer. Biomed Pharmacother., 55, 543-547.
3. Smyth, M. J., Cretney, E., Kershaw, M. H. and Hayakawa, Y. (2004) Cytokines in cancer immunity and immunotherapy. Immunol. Rev., 202, 275-293.
4. Wu, M. S., Huang, S. P., Chang, Y. T., Shun, C. T., Chang, M. C., Lin, M. T., Wang, H. P. and Lin, J. T. (2002) Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J. Infect. Dis., 185, 106-109.
5. Eskdale, J., Kube, D., Tesch, H. and Gallagher, G. (1997) Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics, 46, 120-128.
6. Turner, D. M., Williams, D. M., Sankaran, D., Lazarus, M. and Sinnott, P. J. (1997) Hutchinson, I. V. (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur. J. Immunogenet., 24, 1-8.
7. Crawley, E., Kay, R., Sillibourne, J., Patel, P., Hutchinson, I. and Woo, P. (1999) Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum., 42, 1101-1108.
8. Rad, R., Dossumbekova, A., Neu, B., Lang, R., Bauer, S., Saur, D., Gerhard, M. and Prinz, C. (2004) Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut, 53, 1082-1089.
9. Ahirwar, D., Mandhani, A. and Mittal, R. D. (2009) Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer. Arch. Med. Res., 40, 97-102.
10. Alonso, R., Suarez, A., Castro, P., Lacave, A. J. and Gutierrez, C. (2005) Influence of interleukin-10 genetic polymorphism on survival rates in melanoma patients with advanced disease. Melanoma Res., 15, 53-60.
11. Alpizar-Alpizar, W., Perez-Perez, G. I., Une, C., Cuenca, P. and Sierra, R. (2005) Association of interleukin-1B and interleukin-1RN polymorphisms with gastric cancer in a high-risk population of Costa Rica. Clin. Exp. Med., 5, 169-176.
12. Andrie, E., Michos, A., Kalampoki, V. et al. (2009) Genetic variants in immunoregulatory genes and risk for childhood lymphomas. Eur. J. Haematol., 83, 334-342.
13. Balasubramanian, S. P., Azmy, I. A., Higham, S. E., Wilson, A. G., Cross, S. S., Cox, A., Brown, N. J. and Reed, M. W. (2006) Interleukin gene polymorphisms and breast cancer: a case control study and systematic literature review. BMC Cancer, 6, 188.
14. Berglund, M., Thunberg, U., Roos, G., Rosenquist, R. and Enblad, G. (2005) The interleukin-10 gene promoter polymorphism (-1082) does not correlate with clinical outcome in diffuse large B-cell lymphoma. Blood, 105, 4894-4895; author reply 4895.
15. Ioana Braicu, E., Mustea, A., Toliat, M. R., Pirvulescu, C., Konsgen, D., Sun, P., Nurnberg, P., Lichtenegger, W. and Sehouli, J. (2007) Polymorphism of IL-1alpha, IL-1beta and IL-10 in patients with advanced ovarian cancer: results of a prospective study with 147 patients. Gynecol. Oncol., 104, 680-685.
16. Colakogullari, M., Ulukaya, E., Yilmaztepe Oral, A., Aymak, F., Basturk, B., Ursavas, A. and Oral, H. B. (2008) The involvement of IL-10, IL-6, IFN-gamma, TNF-alpha and TGF-beta gene polymorphisms among Turkish lung cancer patients. Cell Biochem. Funct., 26, 283-290.
17. Cozar, J. M., Romero, J. M., Aptsiauri, N., Vazquez, F., Vilchez, J. R., Tallada, M., Garrido, F. and Ruiz-Cabello, F. (2007) High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer. Hum. Immunol., 68, 698-704.
18. Crivello, A., Giacalone, A., Vaglica, M. et al. (2006) Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma. Ann. N. Y. Acad. Sci., 1089, 98-103.
19. Cunningham, L. M., Chapman, C., Dunstan, R., Bell, M. C. and Joske, D. J. (2003) Polymorphisms in the interleukin 10 gene promoter are associated with susceptibility to aggressive non-Hodgkin's lymphoma. Leuk. Lymphoma, 44, 251-255.
20. Deans, C., Rose-Zerilli, M., Wigmore, S., Ross, J., Howell, M., Jackson, A., Grimble, R. and Fearon, K. (2007) Host cytokine genotype is related to adverse prognosis and systemic inflammation in gastro-oesophageal cancer. Ann. Surg. Oncol., 14, 329-339.
21. El-Omar, E. M., Rabkin, C. S., Gammon, M. D. et al. (2003) Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology, 124, 1193-1201.
22. Erdogan, M., Karadeniz, M., Ozbek, M., Ozgen, A. G. and Berdeli, A. (2008) Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population. J. Endocrinol. Invest., 31, 750-754.
23. Faupel-Badger, J. M., Kidd, L. C., Albanes, D., Virtamo, J., Woodson, K. and Tangrea, J. A. (2008) Association of IL-10 polymorphisms with prostate cancer risk and grade of disease. Cancer Causes Control, 19, 119-124.
24. Garcia-Gonzalez, M. A., Lanas, A., Quintero, E. et al. (2007) Gastric cancer susceptibility is not linked to pro-and anti-inflammatory cytokine gene polymorphisms in whites: a Nationwide Multicenter Study in Spain. Am. J. Gastroenterol., 102, 1878-1892.
25. Giordani, L., Bruzzi, P., Lasalandra, C., Quaranta, M., Schittulli, F., Della Ragione, F. and Iolascon, A. (2003) Association of breast cancer and polymorphisms of interleukin-10 and tumor necrosis factor-alpha genes. Clin. Chem., 49, 1664-1667.
26. Gonullu, G., Basturk, B., Evrensel, T., Oral, B., Gozkaman, A. and Manavoglu, O. (2007) Association of breast cancer and cytokine gene polymorphism in Turkish women. Saudi Med. J., 28, 1728-1733.
27. Guzowski, D., Chandrasekaran, A., Gawel, C. et al. (2005) Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J. Biomol. Tech., 16, 154-166.
28. Havranek, E., Howell, W. M., Fussell, H. M., Whelan, J. A., Whelan, M. A. and Pandha, H. S. (2005) An interleukin-10 promoter polymorphism may influence tumor development in renal cell carcinoma. J. Urol., 173, 709-712.
29. Kamangar, F., Abnet, C. C., Hutchinson, A. A. et al. (2006) Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control, 17, 117-125.
30. Kang, J. M., Kim, N., Lee, D. H., Park, J. H., Lee, M. K., Kim, J. S., Jung, H. C. and Song, I. S. (2009) The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J. Clin. Gastroenterol., 43, 420-428.
31. Kong, F., Liu, J., Liu, Y., Song, B., Wang, H. and Liu, W. (2010) Association of interleukin-10 gene polymorphisms with breast cancer in a Chinese population. J. Exp. Clin. Cancer Res., 29, 72.
32. Kube, D., Hua, T. D., Kloss, M., Kulle, B., Brockmoller, J., Wojnowski, L., Loffler, M., Pfreundschuh, M. and Trumper, L. (2007) The interleukin-10 gene promoter polymorphism -1087AG does not correlate with clinical outcome in non-Hodgkin's lymphoma. Genes Immun., 8, 164-167.
33. Lan, Q., Zheng, T., Rothman, N. et al. (2006) Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma. Blood, 107, 4101-4108.
34. Lee, J. Y., Kim, H. Y., Kim, K. H., Kim, S. M., Jang, M. K., Park, J. Y., Lee, J. H., Kim, J. H. and Yoo, J. Y. (2005) Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Lett., 225, 207-214.
35. Macarthur, M., Sharp, L., Hold, G. L., Little, J. and El-Omar, E. M. (2005) The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland. Cancer Epidemiol. Biomarkers Prev., 14, 1613-1618.
36. Lech-Maranda, E., Baseggio, L., Bienvenu, J., Charlot, C., Berger, F., Rigal, D., Warzocha, K., Coiffier, B. and Salles, G. (2004) Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma. Blood, 103, 3529-3534.
37. Lech-Maranda, E., Baseggio, L., Charlot, C., Rigal, D., Berger, F., Jamroziak, K., Warzocha, K., Coiffier, B. and Salles, G. (2007) Genetic polymorphisms in the proximal IL-10 promoter and susceptibility to non-Hodgkin lymphoma. Leuk. Lymphoma, 48, 2235-2238.
38. Martinez-Escribano, J. A., Moya-Quiles, M. R., Muro, M., Montes-Ares, O., Hernandez-Caselles, T., Frias, J. F. and Alvarez-Lopez, M. R. (2002) Interleukin-10, interleukin-6 and interferon-gamma gene polymorphisms in melanoma patients. Melanoma Res., 12, 465-469.
39. Matsumoto, K., Oki, A., Satoh, T. et al. (2010) Interleukin-10 -1082 gene polymorphism and susceptibility to cervical cancer among Japanese women. Jpn. J. Clin. Oncol., 40, 1113-1116.
40. Mazur, G., Bogunia-Kubik, K., Wrobel, T., Karabon, L., Polak, M., Kuliczkowski, K. and Lange, A. (2005) IL-6 and IL-10 promoter gene polymorphisms do not associate with the susceptibility for multiple myeloma. Immunol. Lett., 96, 241-246.
41. McCarron, S. L., Edwards, S., Evans, P. R. et al. (2002) Influence of cytokine gene polymorphisms on the development of prostate cancer. Cancer Res., 62, 3369-3372.
42. Michaud, D. S., Daugherty, S. E., Berndt, S. I., Platz, E. A., Yeager, M., Crawford, E. D., Hsing, A., Huang, W. Y. and Hayes, R. B. (2006) Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. Cancer Res., 66, 4525-4530.
43. Morgan, D. R., Dominguez, R. L., Keku, T. O., Heidt, P. E., Martin, C. F., Galanko, J. A., Omofoye, O. A. and Sandler, R. S. (2006) Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. Clin. Gastroenterol. Hepatol., 4, 1103-1111.
44. Munro, L. R., Johnston, P. W., Marshall, N. A., Canning, S. J., Hewitt, S. G., Tveita, K. and Vickers, M. A. (2003) Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma. Leuk. Lymphoma, 44, 2083-2088.
45. Nieters, A., Yuan, J. M., Sun, C. L., Zhang, Z. Q., Stoehlmacher, J., Govindarajan, S. and Yu, M. C. (2005) Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association. Cancer, 103, 740-748.
46. Oliveira, I. D., Petrilli, A. S., Tavela, M. H., Zago, M. A. and de Toledo, S. R. (2007) TNF-alpha, TNF-beta, IL-6, IL-10, PECAM-1 and the MPO inflammatory gene polymorphisms in osteosarcoma. J. Pediatr. Hematol. Oncol., 29, 293-297.
47. Onay, V. U., Briollais, L., Knight, J. A. et al. (2006) SNP-SNP interactions in breast cancer susceptibility. BMC Cancer, 6, 114.
48. Pratesi, C., Bortolin, M. T., Bidoli, E. et al. (2006) Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol. Immunother., 55, 23-30.
49. Purdue, M. P., Lan, Q., Kricker, A. et al. (2007) Polymorphisms in immune function genes and risk of non-Hodgkin lymphoma: findings from the New South Wales non-Hodgkin Lymphoma Study. Carcinogenesis, 28, 704-712.
50. Purdue, M. P., Sakoda, L. C., Graubard, B. I., Welch, R., Chanock, S. J., Sesterhenn, I. A., Rubertone, M. V., Erickson, R. L. and McGlynn, K. A. (2007) A case-control investigation of immune function gene polymorphisms and risk of testicular germ cell tumors. Cancer Epidemiol. Biomarkers Prev., 16, 77-83.
51. Schoof, N., von Bonin, F., Konig, I. R. et al. (2009) Distal and proximal interleukin (IL)-10 promoter polymorphisms associated with risk of cutaneous melanoma development: a case-control study. Genes Immun., 10, 586-590.
52. Scola, L., Vaglica, M., Crivello, A. et al. (2006) Cytokine gene polymorphisms and breast cancer susceptibility. Ann. N. Y. Acad. Sci., 1089, 104-109.
53. Scola, L., Giacalone, A., Marasa, L. et al. (2009) Genetic determined downregulation of both type 1 and type 2 cytokine pathways might be protective against pancreatic cancer. Ann. N. Y. Acad. Sci., 1155, 284-288.
54. Seifart, C., Plagens, A., Dempfle, A., Clostermann, U., Vogelmeier, C., von Wichert, P. and Seifart, U. (2005) TNF-alpha, TNF-beta, IL-6, and IL-10 polymorphisms in patients with lung cancer. Dis. Markers, 21, 157-165.
55. Shih, C. M., Lee, Y. L., Chiou, H. L., Hsu, W. F., Chen, W. E., Chou, M. C. and Lin, L. Y. (2005) The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer. Lung Cancer, 50, 291-297.
56. Smith, K. C., Bateman, A. C., Fussell, H. M. and Howell, W. M. (2004) Cytokine gene polymorphisms and breast cancer susceptibility and prognosis. Eur. J. Immunogenet., 31, 167-173.
57. Stanczuk, G. A., Sibanda, E. N., Perrey, C., Chirara, M., Pravica, V., Hutchinson, I. V. and Tswana, S. A. (2001) Cancer of the uterine cervix may be significantly associated with a gene polymorphism coding for increased IL-10 production. Int. J. Cancer, 94, 792-794.
58. Sugimoto, M., Furuta, T., Shirai, N., Nakamura, A., Kajimura, M., Sugimura, H. and Hishida, A. (2007) Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J. Gastroenterol. Hepatol., 22, 1443-1449.
59. Tsilidis, K. K., Helzlsouer, K. J., Smith, M. W., Grinberg, V., Hoffman-Bolton, J., Clipp, S. L., Visvanathan, K. and Platz, E. A. (2009) Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control, 20, 1739-1751.
60. VanCleave, T. T., Moore, J. H., Benford, M. L., Brock, G. N., Kalbfleisch, T., Baumgartner, R. N., Lillard, J. W., Jr., Kittles, R. A. and Kidd, L. C. (2010) Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk. Prostate, 70, 341-352.
61. Wang, M. H., Helzlsouer, K. J., Smith, M. W. et al. (2009) Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate, 69, 874-885.
62. Wei, Y. S., Kuang, X. H., Zhu, Y. H., Liang, W. B., Yang, Z. H., Tai, S. H., Zhao, Y. and Zhang, L. (2007) Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Tissue Antigens, 70, 12-17.
63. Wilkening, S., Hemminki, K., Rudnai, P., Gurzau, E., Koppova, K., Kumar, R. and Forsti, A. (2006) Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA. Br. J. Dermatol., 155, 1139-1144.
64. Wilkening, S., Tavelin, B., Canzian, F. et al. (2008) Interleukin promoter polymorphisms and prognosis in colorectal cancer. Carcinogenesis, 29, 1202-1206.
65. Wu, M. S., Wu, C. Y., Chen, C. J., Lin, M. T., Shun, C. T. and Lin, J. T. (2003) Interleukin-10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese. Int. J. Cancer, 104, 617-623.
66. Zabaleta, J., Lin, H. Y., Sierra, R. A., Hall, M. C., Clark, P. E., Sartor, O. A., Hu, J. J. and Ochoa, A. C. (2008) Interactions of cytokine gene polymorphisms in prostate cancer risk. Carcinogenesis, 29, 573-578.
67. Zambon, C. F., Basso, D., Navaglia, F. et al. (2005) Pro- and antiinflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine, 29, 141-152.
68. Zheng, C., Huang, D., Liu, L. et al. (2001) Interleukin-10 gene promoter polymorphisms in multiple myeloma. Int. J. Cancer, 95, 184-188.
69. Zoodsma, M., Nolte, I. M., Schipper, M., Oosterom, E., van der Steege, G., de Vries, E. G., Te Meerman, G. J. and van der Zee, A. G. (2005) Interleukin-10 and Fas polymorphisms and susceptibility for (pre)neoplastic cervical disease. Int J Gynecol Cancer, 15 (Suppl. 3), 282-290.
70. Romero, J. M., Saenz-Lopez, P., Cozar, J. M. et al. (2009) A polymorphism in the interleukin-10 promoter affects the course of disease in patients with clear-cell renal carcinoma. Hum. Immunol., 70, 60-64.
71. Vairaktaris, E., Yapijakis, C., Serefoglou, Z. et al. (2008) The interleukin- 10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma. Anticancer Res., 28, 309-314.
72. Breslow, N. E. and Day, N. E. (1987) Statistical methods in cancer research. Volume II-The design and analysis of cohort studies. IARC Sci. Publ., 2, 1-406.
73. Higgins, J. P., Thompson, S. G. and Deeks, J. J. (2003) Altman, D. G. (2003) Measuring inconsistency in meta-analyses. BMJ, 327, 557-560.
74. Midgette, A. S., Wong, J. B., Beshansky, J. R., Porath, A., Fleming, C. and Pauker, S. G. (1994) Cost-effectiveness of streptokinase for acute myocardial infarction: a combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Med. Decis. Making, 14, 108-117.
75. Whitehead, A. and Whitehead, J. (1991) A general parametric approach to the meta-analysis of randomized clinical trials. Stat. Med., 10, 1665-1677.
76. Thakkinstian, A., McElduff, P., D'Este, C., Duffy, D. and Attia, J. (2005) A method for meta-analysis of molecular association studies. Stat. Med., 24, 1291-1306.
77. Kamiya, T., Hatanaka, H., Abe, Y. et al. (2003) Interleukin-10 expression is closely correlated with the expression of granulocyte-macrophage colony-stimulating factor in non-small cell lung cancer. Anticancer Res., 23, 2909-2913.
78. Pisa, P., Halapi, E., Pisa, E. K., Gerdin, E., Hising, C., Bucht, A., Gerdin, B. and Kiessling, R. (1992) Selective expression of interleukin 10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. Proc. Natl Acad. Sci. U S A, 89, 7708-7712.
79. Huang, M., Wang, J., Lee, P. et al. (1995) Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res., 55, 3847-3853.
80. Salazar-Onfray, F.,Petersson,M., Franksson,L.,Matsuda,M.,Blankenstein,T., Karre, K. and Kiessling, R. (1995) IL-10 converts mouse lymphoma cells to a CTL-resistant, NK-sensitive phenotype with low but peptide-inducible MHC class I expression. J. Immunol., 154, 6291-6298.
81. Matsuda, M., Salazar, F., Petersson, M., Masucci, G., Hansson, J., Pisa, P., Zhang, Q. J., Masucci, M. G. and Kiessling, R. (1994) Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J. Exp. Med., 180, 2371-2376.
82. Kang, X., Kim, H. J., Ramirez, M., Salameh, S. and Ma, X. (2010) The septic shock-associated IL-10 -1082 A. G polymorphism mediates allelespecific transcription via poly(ADP-Ribose) polymerase 1 in macrophages engulfing apoptotic cells. J. Immunol., 184, 3718-3724.
83. Fortis, C., Foppoli, M., Gianotti, L., Galli, L., Citterio, G., Consogno, G., Gentilini, O. and Braga, M. (1996) Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett., 104, 1-5.
84. Eskdale, J. and Gallagher, G. (1995) A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics, 42, 444-445.
85. Voorzanger, N., Touitou, R., Garcia, E., Delecluse, H. J., Rousset, F., Joab, I., Favrot, M. C. and Blay, J. Y. (1996) Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res., 56, 5499-5505.